Xueli Tian Selected Research

Xueli Tian Research Topics

Disease

12	Neoplasms (Cancer) 04/2024 - 01/2019
5	Infections 03/2024 - 01/2017
4	Lung Neoplasms (Lung Cancer) 10/2022 - 01/2021
3	Esophageal Squamous Cell Carcinoma 04/2023 - 10/2021
3	Stomach Neoplasms (Stomach Cancer) 03/2023 - 01/2021
2	Colonic Neoplasms (Colon Cancer) 04/2024 - 01/2019
2	Hypersensitivity (Allergy) 03/2024 - 04/2023
2	Melanoma (Melanoma, Malignant) 01/2023 - 01/2021
1	Anorexia 04/2023
1	Nausea 04/2023
1	Dizziness (Lightheadedness) 04/2023
1	Colorectal Neoplasms (Colorectal Cancer) 01/2023
1	COVID-19 10/2022
1	Metaplasia 09/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022
1	African Trypanosomiasis (Nagana) 01/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2018

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 04/2024 - 01/2019
3	BismuthIBA 03/2024 - 01/2017
3	Penicillins (Penicillin)FDA Link 03/2024 - 01/2017
3	Amoxicillin (Wymox)FDA LinkGeneric 03/2024 - 01/2017
2	Cefuroxime (Zinacef)FDA LinkGeneric 03/2024 - 01/2017
2	Monoclonal AntibodiesIBA 01/2023 - 01/2021
2	Granzymes (Granzyme)IBA 01/2023 - 01/2021
2	PerforinIBA 01/2023 - 01/2021
2	3,3'-diindolylmethane (diindolylmethane)IBA 01/2022 - 01/2019
2	Esomeprazole (Nexium)FDA Link 12/2020 - 01/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2024
1	Messenger RNA (mRNA)IBA 04/2024
1	LigandsIBA 04/2024
1	SARS-CoV-2 spike proteinIBA 04/2024
1	Clarithromycin (Biaxin)FDA LinkGeneric 06/2023
1	toosendaninIBA 04/2023
1	Peptide Elongation Factor 2 (EF-2)IBA 04/2023
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 04/2023
1	Metronidazole (Metric)FDA LinkGeneric 04/2023
1	Minocycline (Cyclops)FDA LinkGeneric 04/2023
1	Proto-Oncogene Proteins B-rafIBA 01/2023
1	ErianinIBA 01/2023
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2023
1	Pentamidine (NebuPent)FDA LinkGeneric 01/2023
1	acetylshikoninIBA 10/2022
1	Peptide Hydrolases (Proteases)FDA Link 10/2022
1	PapainIBA 10/2022
1	costunolideIBA 10/2022
1	osimertinibIBA 10/2022
1	AntralIBA 09/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	delta-1-pyrroline-5-carboxylateIBA 01/2022
1	indoleIBA 01/2022
1	icotinibIBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	Eflornithine (Ornidyl)FDA Link 01/2022
1	AzidesIBA 01/2022
1	CopperIBA 01/2022
1	Oxidoreductases (Dehydrogenase)IBA 01/2022
1	Proline (L-Proline)FDA Link 01/2022
1	TriazolesIBA 01/2022
1	adhesion receptorIBA 10/2021
1	IntegrinsIBA 10/2021
1	Indomethacin (Indometacin)FDA LinkGeneric 10/2021
1	CytokinesIBA 01/2021
1	Ligases (Synthetase)IBA 01/2021
1	atezolizumabIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	glutamyl-prolyl-tRNA synthetaseIBA 01/2021
1	CateninsIBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2019
1	Dinoprostone (PGE2)FDA Link 01/2019
1	Transcription Factors (Transcription Factor)IBA 10/2018
1	Levofloxacin (Levaquin)FDA Link 01/2017

Therapy/Procedure

10	Therapeutics 04/2024 - 01/2017
3	Immunotherapy 04/2024 - 01/2021
1	Gastrectomy 03/2023
1	Proton Therapy 12/2020
1	Drug Therapy (Chemotherapy) 01/2019
1	Oral Administration 01/2019